• SENSEX 81,306.85
    -693.86 (--0.85%)
  • BANKNIFTY 55,149.40
    -606.05 (--1.09%)
  • N S D L
    1,307.00 1,425.00(%)
  • Apollo Micro Sys
    240.60 240.60(%)
  • Vodafone Idea
    7.29 16.55(%)
  • Netweb Technol.
    2,361.20 3,060.00(%)
  • Ola Electric
    46.90 39.58(%)
  • GOCL Corpn.
    401.00 517.00(%)
  • R Systems Intl.
    496.95 557.80(%)
  • Bharat Forge
    1,120.45 919.10(%)
  • Hind.Aeronautics
    4,462.05 3,045.95(%)
  • Oswal Agro Mills
    83.00 110.69(%)
  • Aditya Bir. Fas.
    81.95 132.82(%)
  • Royal Orch.Hotel
    495.55 495.55(%)
  • M & M
    3,419.70 3,430.00(%)
  • ITC
    397.50 391.50(%)
  • Suzlon Energy
    59.28 86.04(%)
  • Reliance Industr
    1,408.00 1,115.55(%)
  • One 97
    1,277.95 1,277.95(%)
  • HDFC Bank
    1,957.60 1,613.40(%)
  • DCX Systems
    285.80 393.00(%)
  • Tata Motors
    678.50 542.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

J B Chemicals & Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • MNC Associate
  • BSE Code : 303.0
  • ISIN : INE572A01036
1,747.90 20 (1.16%)
  • As on 24 Aug 2025 (EOD)

  • Today’s Low

    1,719.40

  • Today’s High

    1,758.80

  • Open

    1,721.10

  • Perv Close

    1,727.90

  • 52W Low

    1,385.75

  • 52W High

    1,991.95

Key Indicators

  • P/E(TTM)

    40.38

  • Mar.Cap (₹Cr.)

    27,346.94

  • Div & Yield %

    0.88

  • Book Value(₹)

    215.86

  • Debt-Equity Ratio

    1.16

  • AGM Date

    22-Aug-2025

  • EPS

    43.28

  • P/E Ratio

    40.38

Financials Ratios

  • Debt-Equity Ratio

    0.18

  • Mar.Cap (₹Cr.)

    27,346.94

  • RONW (%)

    20.45

  • ROCE (%)

    24.90

Score Board

  • Equity (₹ in Cr.)

    15.65

  • BV (₹)

    215.90

  • Sales( ₹ in Cr.)

    3,722.92

  • NP (in Cr.)

    632.54

  • NP Var(%)

    19.0

  • Div%

    1550.0

  • CPS (₹)

    51.10

  • EPS (₹)

    40.40

  • Traded Value (₹ in Lakhs)

    27,343.82

  • 52 Week High

    1,991.95

  • 52 Week Low

    1,385.75

  • Price BSE

    1748.0

  • Price NSE

    1,748.00

  • Market Capital( in Cr.)

    27,343.82

  • P/C Ratio

    34.20

  • P/E Ratio

    43.20

  • Price Vs.BV

    40.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 3,722.92 3,298.64 2,884.16 2,189.88 1,892.00 1,640.74
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 3,722.92 3,298.64 2,884.16 2,189.88 1,892.00 1,640.74
Other Income 34.74 34.67 8.65 38.61 115.92 47.13
Stock Adjustments -15.53 49.22 27.48 25.57 15.70 -2.53
Total Income 3,742.13 3,382.53 2,920.29 2,254.06 2,023.62 1,685.34
EXPENDITURE :            
Raw Materials 1,236.70 1,158.29 1,064.21 769.27 641.46 566.61
Power and Fuel Cost 83.83 87.95 91.44 71.37 62.60 61.54
Employee Cost 646.79 565.38 499.95 399.06 305.98 293.78
Other Manufacturing Expenses 143.79 120.93 106.13 97.36 84.69 77.06
Selling and Administration Expenses 491.43 446.93 394.90 305.91 204.68 205.02
Miscellaneous Expenses 86.92 88.96 90.33 63.58 55.96 73.75
Employee Benefit Expenses 646.79 565.38 499.95 399.06 305.98 293.78
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,689.46 2,468.44 2,246.95 1,706.54 1,355.37 1,277.77
Operating Profit 1,052.68 914.09 673.34 547.52 668.25 407.59
Interest 9.12 40.52 34.31 4.95 7.19 2.94
Gross Profit 1,043.56 873.57 639.03 542.57 661.06 404.65
Depreciation 166.45 135.24 111.99 71.28 67.36 65.09
Profit Before Tax 877.11 738.33 527.04 471.29 593.70 339.56
Current Tax 191.69 145.49 83.35 122.50 137.50 82.02
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 32.88 49.49 54.80 -12.21 9.12 -10.60
Reported Net Profit 652.54 543.36 388.89 361.00 447.08 268.14
Extraordinary Items 20.00 11.70 2.92 27.75 46.97 12.62
Adjusted Net Profit 632.54 531.66 385.97 333.25 400.11 255.52
Adjustment below Net Profit -4.43 -3.71 0.13 0.07 -12.50 -5.06
P & L Balance brought forward 2,452.82 2,070.16 1,808.73 1,575.18 1,214.01 1,092.46
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 237.04 156.99 127.59 127.52 73.42 141.53
P & L Balance carried down 2,863.89 2,452.82 2,070.16 1,808.73 1,575.18 1,214.01
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,550.00 1,225.00 887.50 825.00 825.00 550.00
Dividend Per Share(Rs) 15.50 12.25 17.75 16.50 16.50 11.00
Earnings Per Share-Unit Curr 41.92 35.01 50.26 46.71 57.85 34.70
Earnings Per Share(Adj)-Unit Curr 41.92 35.01 25.13 23.36 28.93 17.35
Book Value 216.94 185.98 315.65 272.21 233.75 187.02
Book Value(Adj)-Unit Curr 216.94 185.98 157.83 136.11 116.88 93.51

Shareholding Pattern

  • Promoter Group

    47.73%

  • Public Share Holding

    52.27%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 74,481,519 74,481,519.00 74,481,519 74,481,519
Sub Total 74,481,519 47.73 74,481,519 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 6,000 0.00 3,000 3
Foreign Bank 1,000 0.00 1,000 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 27,730,661 17.77 27,730,661 253
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4,186,618 2.68 4,183,618 12
Mutual Funds / UTI 25,395,176 16.27 25,393,176 31
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,043,875 0.67 1,043,875 11
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 58,363,330 37.40 58,355,330 311
2] Non Institution
Bodies Corporate 651,511 0.42 646,511 419
Clearing Members 11,849 0.01 11,849 5
Directors of their Relatives 50,000 0.03 50,000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,023,354 0.66 1,023,354 1,911
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 517,080 0.33 517,080 1,039
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,459,450 0.94 1,459,450 2
Individuals holding nominal share capital up to Rs. 1 lakh 18,897,993 12.11 18,428,623 66,368
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 4,145 0.00 4,145 5
Others 598,693 0.38 598,693 2
Sub Total 23,214,075 14.88 22,739,705 69,752
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 156,058,924 100.00 155,576,554 70,064

Company Background

J B Chemicals & Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • J B Chemicals & Pharmaceuticals Ltd
  • BSE Code : 303.0
  • ISIN : INE572A01036

  • Incorporation Year

    1976

  • Registered Office

    Neelam Centre 4th Floor
    B-Wing Hind Cycle Road Worli, Mumbai,
    Maharashtra-400030

  • Telephone

    91-022-2482 2222/2493 0918

  • FAX

    91-022-24930534

  • Chairman

    Arun Duggal

  • Managing Director

  • Company Secretary

    SANDEEP PHADNIS

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Datamatics Financial Services
    Plot No B-5 MIDC ,
    Part B Cross Lane ,Marol Andheri(E)
    Mumbai - Mumbai-400093

J B Chemicals & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
J B Chemicals & 1,747.70 3,757.66 3,722.92 40.38 26.54
Abbott India 31,909.75 6,684.73 6,409.15 46.69 44.95
Astrazeneca Phar 8,431.65 1,756.92 1,716.29 114.97 32.94
P & G Health Ltd 6,573.80 944.52 934.17 36.30 40.23
Glaxosmi. Pharma 2,799.50 3,866.05 3,723.49 50.34 58.72
Cipla 1,592.30 20,029.57 19,044.85 23.80 21.40
Amrutanjan Healt 701.35 437.58 421.23 37.19 20.84
Guj. Themis Bio. 399.70 152.47 150.80 97.73 27.21
Fermenta Biotec. 336.10 442.21 430.53 11.15 17.61
Bliss GVS Pharma 161.45 703.42 667.20 24.13 9.16
Ambalal Sarabhai 34.33 19.33 4.04 17.97 2.10